InvestorsHub Logo
Followers 8
Posts 2018
Boards Moderated 0
Alias Born 07/19/2006

Re: gr8db8 post# 286

Wednesday, 05/18/2016 5:32:12 PM

Wednesday, May 18, 2016 5:32:12 PM

Post# of 2099
I would like to compare the low dose cohort to the therapeutic cohort in terms of survival, progression free survival, ect... but this will have to wait a few weeks till ASCO. As to the expected overall survival in patients who fail platinum and avastin, I believe the numbers are pretty bleak. Am I reading these numbers right? or is the dataset looking very encouraging.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News